3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
255
Neoplasms
220
Carcinoma, Non-Small-Cell Lung
201
Colorectal Neoplasms
146
Prostatic Neoplasms
136
Lung Neoplasms
118
Ovarian Neoplasms
100
Neoplasm Metastasis
100
Multiple Myeloma
96
Pancreatic Neoplasms
89
Leukemia, Myeloid, Acute
80
Squamous Cell Carcinoma of Head and Neck
70
Melanoma
64
Endometrial Neoplasms
64
Stomach Neoplasms
59
Recurrence
57
Glioblastoma
55
Brain Neoplasms
54
Urinary Bladder Neoplasms
51
Precursor Cell Lymphoblastic Leukemia-Lymphoma
50
Carcinoma, Hepatocellular
50
Lymphoma
48
Triple Negative Breast Neoplasms
47
Carcinoma, Renal Cell
45
Head and Neck Neoplasms
44
Esophageal Neoplasms
44
Glioma
43
Lymphoma, Non-Hodgkin
42
Hematologic Neoplasms
42
Uterine Cervical Neoplasms
39
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liver Cirrhosis
×
30 days
×
Clear all
NCT05692024
2026-05-05
COMMENCER
Massachusetts General Hospital
Phase 1/2
Recruiting
80 enrolled